Chronic Kidney Disease Stage Progression in Liver Transplant Recipients
John C. LaMattina(Massachusetts General Hospital), Arjang Djamali(MaineHealth), Julio Pascual(Universidad de Cantabria), Glen Leverson(University of Wisconsin–Madison), Milagros Samaniego(Henry Ford Health System), David P. Foley(Beaumont Hospital), Munoz D.R. Alejandro, Luis A. Fernandez(University of Wisconsin–Madison), Anthony M. D’Alessandro(University of Wisconsin–Madison), John D. Pirsch(University of Wisconsin–Madison), Alexandru I. Musat(University of Wisconsin–Madison), Vijay Vidyasagar(University of Wisconsin–Madison), Joshua D. Mezrich(University of Wisconsin–Madison)
Cited by 39
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
|Gastroenterology|2012|589
Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
|American Journal of Transplantation|2003|380
ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation
|American Journal of Transplantation|2009|373
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
|Antimicrobial Agents and Chemotherapy|2000|363